ecrin-mdr-crc0000Clinical2023Colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/89220China7ECRIN MDRNot yet recruiting0falseStereotactic ablative radiotherapy in combination with bevacizumab and anti-PD-L1 in patients with liver metastases from colorectal cancer of MSS: a prospective, single-arm, single-center, exploratory clinical trialInterventions: Group of colorectal cancer:SBRT+bevacizumab+Envafolimab Primary outcome(s): Objective remission rate of disease Study Design: Single arm2023-07-1589220ChiCTR2300073116